Company
Headquarters: Hsinchu City, Taiwan
TW$322.9 Million
TWD as of Jan. 1, 2024
US$10.5 Million
| Company | Market Cap (USD) |
|---|---|
| Novo Nordisk | $461.52 B |
| Vertex Pharmaceuticals Incorporated | $107.23 B |
| Regeneron Pharmaceuticals, Inc. | $100.01 B |
| CSL Limited | $94.74 B |
| Marinomed Biotech AG | $73.23 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Visgeneer Inc., a biotech company, develops and produces biomedical products in the fields of medical device, cosmetics/skin care, bacterial fermentation, and cancer gene identification. The company offers blood glucose and ketone, and uric acid monitoring systems. It also provides multi-active cream gels, wrinkle reducing eye creams, hydro complete emulsions, revitalizing essences, toning lotions, amino acid cleansing creams, multi-perfection firming gel creams, aqua emulsions, herbal gel lotions, anti- aging creams, brightening serums, revitalizing lotions, masks, UV shield creams, dark spot corrector pearl whitening cream, anti-acne complexes, glucosamine creams, essences, hyaluronic acid and intensive whitening essences, rejuvenating essence creams, and anti-aging time complex capsules under Coresence name. Visgeneer Inc. is based in Hsinchu City, Taiwan.
Top 1-year algo backtest: +269.94%
$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Visgeneer, Inc. has the following listings and related stock indices.
Stock: TWSE: 4197 wb_incandescent